Sfoglia per RIVISTA
ANNALS OF ONCOLOGY : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Collezione AOU San Luigi di Orbassano

  

Items : 30

Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):631. doi: 10.1016/j.annonc.2022.12.006. Epub 2022 Dec 21.

2023
AOU San Luigi di Orbassano

Berruti A; Terzolo M; de Krijger R; Porpiglia F; Haak HR; Fouchardiere C; Baudin E; Eisenhofer G; Assie G; Fassnacht M;

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Rizzo M; Spina F; Milesi L; De Vivo R; Masini C; Merler S; Ermacora P; Verri E; Galli L; Carella C; Santini D; Buti S; Caserta C; Buttigliero C; Battelli N; Ciccarese C; Brunelli M; Iacovelli R; Sperduti I; Fornarini G; Tortora G;

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5.

2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano

Scagliotti GV; Caffo O; Irtelli L; Wiest G; Monica V; Porcu L; Manegold C; Dickgreber NJ; Bearz A; Pedrazzoli P; Follador A; Folprecht G; Griesinger F; Schmid-Bindert G; Reck M; Morabito A; Santo A; Gregorc V; Chiari R; Schena M; Borra G; Valmadre G; Ceribelli A; Kropf-Sanchen C; Stoelben E; Geissler M; Colantonio I; Cauchi C; Ladage D; et alii...

Malignant pleural mesothelioma: new guidelines make us stronger for defeating this disease. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Feb;33(2):123-125. doi: 10.1016/j.annonc.2021.11.019. Epub 2021 Dec 6.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Bironzo P; Hendriks LEL; Remon J;

Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Apr;33(4):454. doi: 10.1016/j.annonc.2022.01.005. Epub 2022 Jan 25.

2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano

Manegold C; Scagliotti GV; Torri V; Grohe C; Porcu L; Follador A; Monica V; Wiest G; Irtelli L; Dickgreber NJ; Bearz A; Caffo O; Pedrazzoli P; Chiari R; Reck M; Schmid-Bindert G; Folprecht G; Griesinger F; Gregorc V; Santo A; Stoelben E; Ceribelli A; Serke M; Morabito A; Schena M; Valmadre G; Borra G; Kropf-Sanchen C; Colantonio I; et alii...

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.

2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli

Zucali P; Tucci M; Verri E; Procopio G; Mucciarini C; Mosca A; Massari F; Fratino L; Masini C; Fornarini G; Ermacora P; Donini M; Buti S; Ceresoli GL; Bortolus R; Berruti A; Baldessari C; Buttigliero C; Zagonel V; Caffo O;

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Nov;31(11):1476-1490. doi: 10.1016/j.annonc.2020.08.2099. Epub 2020 Aug 27.

2020
AOU San Luigi di Orbassano

Terzolo M; de Krijger R; Porpiglia F; Haak HR; de la Fouchardiere C; Baudin E; Eisenhofer G; Assie G; Fassnacht M; Berruti A;

ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 May;31(5):609-618. doi: 10.1016/j.annonc.2020.02.006. Epub 2020 Feb 20.

2020
AOU San Luigi di Orbassano

McCleod M; Park K; Soo R; Takeda Y; Marquez-Medina D; Novello S; Mandziuk S; Sugawara S; Fischer JR; Orlov S; Reinmuth N; Planchard D; Geater SL; Powell M; May R; Scheuring U; Stockman P; Kowalski D;

Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ?1% by the USA Food and Drug Administration. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Nov 1;30(11):1686-1688. doi: 10.1093/annonc/mdz295.

2019
AOU San Luigi di Orbassano

Tan D; Rolfo C; Reck M; Pennell NA; Peled N; Liu SV; Dingemans AM; Cufer T; Califano R; Blais N; Novello S; Remon J; Mountzios G; Vansteenkiste J; West H; Besse B;

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.

2018
AOU San Luigi di Orbassano

Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449.

2018
AOU San Luigi di Orbassano

Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;

New European Clinical Trial Regulation: perception and expectations in Italy. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Jul 1;28(7):1648-1654. doi: 10.1093/annonc/mdx153.

2017
AOU San Luigi di Orbassano

Cagnazzo C; Campora S; Ferretti E; Arizio F; Marchesi E;

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.

2017
AOU San Luigi di Orbassano

Cremolini C; Morano F; Moretto R; Berenato R; Tamborini E; Perrone F; Rossini D; Gloghini A; Busico A; Zucchelli G; Baratelli C; Tamburini E; Tampellini M; Sensi E; Fucà G; Volpi C; Milione M; Di Maio M; Fontanini G; De Braud F; Falcone A; Pietrantonio F;

Results of an integrated multi-platforms analysis in squamous cell lung carcinoma (SqCLC) revealed PI3K/RICTOR-mTORC2 axis as a potential prognostic biomarker and druggable target in Annals of oncology : official journal of the European Society for Medical Oncology

2017
AOU San Luigi di Orbassano

Pilotto S; Simbolo M; Gkountakos A; Mafficini A; Vicentini C; Sperduti I; Ludovini V; Chiari R; Novello S; Milella M; Carbognin L; Caregnato E; Santo A; Infante M; Brunelli M; Corbo V; Scarpa A; Tortora G; Bria E;

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.

2016
AOU San Luigi di Orbassano

Novello S; Barlesi F; Califano R; Cufer T; Ekman S; Levra MG; Kerr K; Popat S; Reck M; Senan S; Simo GV; Vansteenkiste J; Peters S;

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Aug;27(8):1612-9. doi: 10.1093/annonc/mdw211. Epub 2016 May 23.

2016
AOU San Luigi di Orbassano

Patel JD; Pereira JR; Chen J; Liu J; Guba SC; John WJ; Orlando M; Scagliotti G; Bonomi PD;

Tivantinib added to erlotinib in nonsmall-cell lung cancer: the primary end point was not MET... in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Oct;26(10):2007-9. doi: 10.1093/annonc/mdv334. Epub 2015 Aug 11.

2015
AOU San Luigi di Orbassano

Scagliotti GV; Di Maio M;

Differences among young adults, adults and elderly chronic myeloid leukemia patients. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jan;26(1):185-192. doi: 10.1093/annonc/mdu490. Epub 2014 Oct 30.

2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Castagnetti F; Gugliotta G; Baccarani M; Breccia M; Specchia G; Levato L; Abruzzese E; Rossi G; Iurlo A; Martino B; Pregno P; Stagno F; Cuneo A; Bonifacio M; Gobbi M; Russo D; Gozzini A; Tiribelli M; de Vivo A; Alimena G; Cavo M; Martinelli G; Pane F; Saglio G; Rosti G;

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Sep;25(9):1681-1690. doi: 10.1093/annonc/mdu145. Epub 2014 Apr 8.

2014
AOU San Luigi di Orbassano

Kerr KM; Bubendorf L; Edelman MJ; Marchetti A; Mok T; Novello S; O'Byrne K; Stahel R; Peters S; Felip E;

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Nov;25(11):2156-2162. doi: 10.1093/annonc/mdu384. Epub 2014 Aug 19.

2014
AOU San Luigi di Orbassano

Novello S; Besse B; Felip E; Barlesi F; Mazieres J; Zalcman G; von Pawel J; Reck M; Cappuzzo F; Ferry D; Carcereny E; Santoro A; Garcia-Ribas I; Scagliotti G; Soria JC;

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231.

2012
AOU San Luigi di Orbassano

Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G;

Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Oct;23(10):2649-2655. doi: 10.1093/annonc/mds100. Epub 2012 Apr 29.

2012
AOU San Luigi di Orbassano

Salah S; Watanabe K; Welter S; Park JS; Park JW; Zabaleta J; Ardissone F; Kim J; Riquet M; Nojiri K; Gisabella M; Kim SY; Tanaka K; Al-Haj Ali B;

Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Dec;23(12):3110-3116. doi: 10.1093/annonc/mds148. Epub 2012 Jun 27.

2012
AOU San Luigi di Orbassano

Giacchetti S; Dugué PA; Innominato PF; Bjarnason GA; Focan C; Garufi C; Tumolo S; Coudert B; Iacobelli S; Smaaland R; Tampellini M; Adam R; Moreau T; Lévi F;

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Aug;23(8):2072-2077. doi: 10.1093/annonc/mdr572. Epub 2012 Jan 4.

2012
AOU San Luigi di Orbassano

Santini D; Tampellini M; Vincenzi B; Ibrahim T; Ortega C; Virzi V; Silvestris N; Berardi R; Masini C; Calipari N; Ottaviani D; Catalano V; Badalamenti G; Giannicola R; Fabbri F; Venditti O; Fratto ME; Mazzara C; Latiano TP; Bertolini F; Petrelli F; Ottone A; Caroti C; Salvatore L; Falcone A; Giordani P; Addeo R; Aglietta M; Cascinu S; et alii...

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Apr;22(4):988-990. doi: 10.1093/annonc/mdr010. Epub 2011 Feb 14.

2011
AOU San Luigi di Orbassano

Bellini E; Pia A; Brizzi MP; Tampellini M; Torta M; Terzolo M; Dogliotti L; Berruti A;

Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2010 Mar;21(3):548-555. doi: 10.1093/annonc/mdp334. Epub 2009 Sep 16.

2010
AOU San Luigi di Orbassano

Righi L; Volante M; Tavaglione V; Billè A; Daniele L; Angusti T; Inzani F; Pelosi G; Rindi G; Papotti M;

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2007 May;18(5):903-8. doi: 10.1093/annonc/mdm061. Epub 2007 Mar 9.

2007
AOU San Luigi di Orbassano

Novello S; Bruzzi P; Barone C; Buosi R; Masotti A; Michetti G; Fioretti M; Barbera S; Spatafora M; Garetto L; Mazzanti P; Dongiovanni V; Selvaggi G; Crinò L; Scagliotti GV;

Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005 Oct;16(10):1662-6. doi: 10.1093/annonc/mdi314. Epub 2005 Jul 8.

2005
AOU San Luigi di Orbassano

Novello S; Fava C; Borasio P; Dogliotti L; Cortese G; Crida B; Selvaggi G; Lausi P; Brizzi MP; Sperone P; Cardinale L; Ferraris F; Perotto F; Priola A; Scagliotti GV;

State of the art in mesothelioma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005;16 Suppl 2:ii240-5. doi: 10.1093/annonc/mdi703.

2005
AOU San Luigi di Orbassano

Scagliotti GV; Novello S;

Multidrug resistance in non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 1999;10 Suppl 5:S83-6. doi: 10.1093/annonc/10.suppl_5.s83.

1999
AOU San Luigi di Orbassano

Scagliotti GV; Novello S; Selvaggi G;